Our Mission statement:
SanBio Develops Regenerative Therapies Addressing Unmet Medical Needs and Creating Value for Stakeholders.
Regenerative Therapies for Neurological Disorders: A New Generation of Products
SanBio, Inc. develops regenerative therapies for neurological disorders. Our products have demonstrated the capability of reversing neural damage in a wide variety of disease models, with the lead product in the early clinical testing.
Novel Medicines at Scale
SanBio uses genetic manipulation of bone marrow stromal cells that, when administered to damaged tissue, promote functional recovery. Bone marrow cells from a single donor can be used to treat thousands of patients.
Based on the considerable progress to date, SanBio anticipates that its products will be among the first cell therapies to demonstrate clear and substantial therapeutic value, and will become a common element in the medical regimen for several important chronic disorders.